Quick Answer
SELLAS Life Sciences Group, Inc. reported Total Assets of $78.35 million for the year ending 2025.
- SELLAS Life Sciences Group, Inc. showed an increase of +303.2% in Total Assets from 2024 to 2025.
- This data is from SELLAS Life Sciences Group, Inc.'s annual report (Form 10-K), filed with the SEC on March 19, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2011: $32.35 million | Q3 2011: $30.33 million | Q1 2012: $28.21 million | Q2 2012: $38.96 million | Q3 2012: $35.19 million | Q1 2013: $61.45 million | Q2 2013: $62.00 million | Q3 2013: $91.25 million | Q1 2014: $92.29 million | Q2 2014: $80.28 million | Q3 2014: $79.49 million | Q1 2015: $108.61 million | Q2 2015: $101.97 million | Q3 2015: $82.67 million | Q1 2016: $66.37 million | Q2 2016: $73.78 million | Q3 2016: $72.85 million | Q1 2017: $70.33 million | Q2 2017: $60.55 million | Q3 2017: $49.60 million | Q1 2018: $33.49 million | Q2 2018: $31.97 million | Q3 2018: $38.47 million | Q1 2019: $14.93 million | Q2 2019: $25.03 million | Q3 2019: $21.48 million | Q1 2020: $17.03 million | Q2 2020: $14.51 million | Q3 2020: $18.51 million | Q1 2021: $40.58 million | Q2 2021: $43.62 million | Q3 2021: $37.95 million | Q1 2022: $21.43 million | Q2 2022: $32.21 million | Q3 2022: $26.00 million | Q1 2023: $29.10 million | Q2 2023: $18.57 million | Q3 2023: $8.09 million | Q1 2024: $24.43 million | Q2 2024: $15.12 million | Q3 2024: $26.51 million | Q1 2025: $34.96 million | Q2 2025: $32.31 million | Q3 2025: $51.56 million.
- Over the full 16 years of available data (2010 to 2025), SELLAS Life Sciences Group, Inc.'s Total Assets has grown by 948.0%.
- Historical annual values: Fiscal year 2025: $78.35 million | Fiscal year 2024: $19.43 million | Fiscal year 2023: $6.22 million | Fiscal year 2022: $20.94 million | Fiscal year 2021: $26.28 million | Fiscal year 2020: $46.05 million | Fiscal year 2019: $16.61 million | Fiscal year 2018: $16.92 million | Fiscal year 2017: $33.53 million | Fiscal year 2016: $6.42 million | Fiscal year 2015: $82.14 million | Fiscal year 2014: $80.49 million | Fiscal year 2013: $87.98 million | Fiscal year 2012: $54.99 million | Fiscal year 2011: $30.97 million | Fiscal year 2010: $7.48 million.
- Data sourced from SEC EDGAR public filings as of August 4, 2026.
Last verified: